Clinical Trial Update: Mobile Health (M-health) Intervention to Reduce the Epigenetic Signature in Metabolic Syndrome (MetS) [NA]

View source ↗

Summary

The clinical trial evaluating a mobile health intervention to reduce epigenetic signatures associated with metabolic syndrome (and obesity) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome
• Obesity

Snippet

Sponsor: Aga Khan University | Conditions: Metabolic Syndrome, Obesity | NA | Status: COMPLETED